Probiodrug's Series D Round

Probiodrug raised a round of funding on January 04, 2012.

Probiodrug is dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory diseases. The company develops therapeu…

Articles about Probiodrug's Series D Round: